Utility of high molecular weight cytokeratins, but not p63, in the differential diagnosis of neuroendocrine and basaloid carcinomas of the head and neck

Human Pathology

Volumn 39, Issue 4, 2008, Pages 591-598

  Serrano, Maria F ^a   El Mofty, Samir K ^a   Gnepp, Douglas R ^b   Lewis Jr , James S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Adenoid cystic carcinoma; Basaloid squamous cell carcinoma; High molecular weight cytokeratin; Immunohistochemistry; Neuroendocrine carcinoma

Indexed keywords

CHROMOGRANIN A; CYTOKERATIN; PROTEIN P63; PROTEIN S 100; SMOOTH MUSCLE ACTIN; SYNAPTOPHYSIN;

ADENOID CYSTIC CARCINOMA; ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROENDOCRINE CARCINOMA; NEUROENDOCRINE DISEASE; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, BASOSQUAMOUS; CARCINOMA, NEUROENDOCRINE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; KERATIN-5; KERATIN-6; KERATINS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; MOLECULAR WEIGHT; TUMOR MARKERS, BIOLOGICAL;

EID: 40649128727     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2007.08.019     Document Type: Article

References (29)

1. Barnes L., Slootweg P., Tse L.L., et al. Tumours of the hypopharynx, larynx, and trachea. In: Barnes L., Evason J.W., Reichart P., et al. (Eds). World Health Organization Classification of Tumours-Pathology and Genetics, Head and Neck Tumours (2005), IARC Press, Lyon (France) 107-162
2. Barker J.L., Glisson B.S., Garden A.S., et al. Management of nonsinonasal neuroendocrine carcinomas of the head and neck. Cancer 98 (2003) 2322-2328
3. Gnepp D.R. Small cell neuroendocrine carcinoma of the larynx. A critical review of the literature. ORL J Otorhinolaryngol Relat Spec 53 (1991) 210-219
4. Zbaren P., Nuyens M., and Stauffer E. Basaloid squamous cell carcinoma of the head and neck. Curr Opin Otolaryngol Head Neck Surg 12 (2004) 116-121
5. Kokemueller H., Eckardt A., Brachvogel P., et al. Adenoid cystic carcinoma of the head and neck-a 20 years experience. Intern J Oral Maxillofac Surg 33 (2003) 25-31
6. Szanto P.A., Luna M.A., Tortoledo M.E., et al. Histologic grading of adenoid cystic carcinoma of the salivary glands. Cancer 54 (1984) 1062-1069
7. Ferlito A., Barnes L., Rinaldo A., et al. A review of neuroendocrine neoplasms of the larynx: update on diagnosis and treatment. J Laryngol Otol 112 (1998) 827-834
8. Jaiswal V., and Hoang M. Primary combined squamous and small cell carcinoma of the larynx. A case report and review of the literature. Arch Pathol Lab Med 128 (2004) 1279-1282
9. Norberg-Spaak L., Dardick I., and Ledin T. Adenoid cystic carcinoma: use of cell proliferation, bcl-2 expression, histologic grade, and clinical stage as predictors of outcome. Head Neck 22 (2000) 489-497
10. Soussi A.C., Benghiat A., Holgate C.S., et al. Neuroendocrine tumors of the head and neck. J Laryngol Otol 104 (1990) 504-507
11. Ferlito A., and Friedmann I. Contribution of immunohistochemistry in the diagnosis of neuroendocrine neoplasms of the larynx. ORL J Otorhinolaryngol Relat Spec 53 (1991) 235-244
12. Rinaldo A., Devaney K.O., and Ferlito A. Immunohistochemical studies in support of a diagnosis of small cell neuroendocrine carcinoma of the larynx. Acta Otolaryngol 124 (2004) 638-641
13. Nicholson S.A., Beasley M.B., Brambilla E., et al. Small cell lung carcinoma (SCLC). A clinicopathologic study of 100 cases with surgical specimens. Am J Surg Pathol 26 (2002) 1184-1197
14. Yang A., Kaghad M., Caput D., et al. On the shoulders of giants: p63, p73, and the rise of p53. Trends Genet 18 (2002) 90-95
15. Weber A., Langhanki L., Schutz A., et al. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Virch Arch 441 (2002) 428-436
16. Emanuel P., Wang B., Wu M., et al. p63 immunohistochemistry in the distinction of adenoid cystic carcinoma from basaloid squamous cell carcinoma. Mod Pathol 18 (2005) 645-650
17. Kaufmann O., Fietze E., Mengs J., et al. Value of p63 and cytokeratin 5/6 as immunohistochemical markers for the differential diagnosis of poorly differentiated and undifferentiated carcinomas. Am J Clin Pathol 116 (2001) 823-830
18. Greene L., Brundage W., and Cooper K. Large cell neuroendocrine carcinoma of the larynx: a case report and review of the classification of this neoplasm. J Clin Pathol 58 (2005) 658-661
19. Banks E.R., Frierson Jr. H.F., Mills S.E., et al. Basaloid squamous cell carcinoma of the head and neck. A clinicopathologic and immunohistochemical study of 40 cases. Am J Surg Pathol 16 (1992) 939-946
20. Morice W.G., and Ferreiro J.A. Distinction of basaloid squamous cell carcinoma from adenoid cystic and small cell undifferentiated carcinoma by immunohistochemistry. Hum Pathol 29 (1998) 609-612
21. Chan J.K., Suster S., Wenig B.M., et al. Cytokeratin 20 immunoreactivity distinguishes Merkel cell (primary cutaneous neuroendocrine) carcinomas and salivary gland small cell carcinomas from small cell carcinomas of various sites. Am J Surg Pathol 21 (1997) 226-234
22. Nagao T., Gaffey T.A., Olsen K.D., et al. Small cell carcinoma of the major salivary glands-clinicopathologic study with emphasis on cytokeratin 20 immunoreactivity and clinical outcome. Am J Surg Pathol 28 (2004) 762-780
23. Zhang H., Liu J., Cagle P.T., et al. Distinction of pulmonary small cell carcinoma from poorly differentiated squamous cell carcinoma: an immunohistochemical approach. Mod Pathol 18 (2005) 111-118
24. Wu M., Wang B., Gil J., et al. p63 and TTF-1 immunostaining-a useful marker panel for distinguishing small cell carcinoma of the lung from poorly differentiated squamous cell carcinoma of the lung. Am J Clin Pathol 119 (2003) 696-702
25. Wang B.Y., Gil J., and Kaufman D. p63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors. Hum Pathol 33 (2002) 921-926
26. Au N.H.C., Gown A.M., Cheang M., et al. p63 expression in lung carcinoma-a tissue microarray study of 408 cases. Appl Immunohistochem Mol Morphol 12 (2004) 240-247
27. Brambilla E., Lantuejoul S., Pugatch B., et al. Large cell carcinoma. In: Travis W., Brambilla E., Muller-Hermelink H.K., et al. (Eds). World Health Organization Classification of Tumours-Pathology and Genetics, Tumours of the Lung, Pleura, Thymus, and Heart (2004), IARC Press, Lyon (France) 45-50
28. Beasley M.B., Geisinger K., Thunnissen F.B., et al. Carcinoid tumor. In: Travis W., Brambilla E., Muller-Hermelink H.K., et al. (Eds). World Health Organization Classification of Tumours-Pathology and Genetics, Tumours of the Lung, Pleura, Thymus, and Heart (2004), IARC Press, Lyon (France) 59-62
29. Nagao T., Sugano I., Ishida Y., et al. Primary large-cell neuroendocrine carcinoma of the parotid gland: immunohistochemical and molecular analysis of two cases. Mod Pathol 13 (2000) 554-561